HEALTHSTREAM INC
For the period ended Dec 31, 2025. Filed Feb 27, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 27, 2026
HSTM$28.85-0.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| December 31, | December 31, | |
|---|---|---|
| 2025 | 2024 | |
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $36,161 | $59,469 |
| Marketable securities | 20,843 | 37,748 |
| Accounts receivable, net | 32,153 | 30,189 |
| Accounts receivable - unbilled | 6,845 | 5,133 |
| Prepaid royalties, net of amortization | 7,638 | 9,547 |
| Prepaid software maintenance and subscriptions | 9,321 | 8,569 |
| Other prepaid expenses and other current assets | 6,695 | 2,467 |
| Total current assets | 119,656 | 153,122 |
| Property and equipment, net | 10,661 | 10,741 |
| Capitalized software development, net | 45,581 | 43,370 |
| Operating lease right of use assets, net | 15,272 | 17,453 |
| Goodwill | 217,518 | 191,220 |
| Intangibles, net | 64,930 | 55,548 |
| Other assets | 46,756 | 39,312 |
| Total assets | $520,374 | $510,766 |
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $7,769 | $6,628 |
| Accrued royalties | 5,595 | 5,190 |
| Accrued liabilities | 11,166 | 10,141 |
| Accrued compensation | 11,199 | 9,507 |
| Deferred revenue | 88,417 | 84,227 |
| Total current liabilities | 124,146 | 115,693 |
| Deferred tax liabilities | 18,246 | 14,596 |
| Deferred revenue, noncurrent | 1,344 | 1,655 |
| Operating lease liability, noncurrent | 14,684 | 17,366 |
| Other long-term liabilities | 7,931 | 2,101 |
| Commitments and contingencies | ||
| Shareholders’ equity: | ||
| Preferred stock, no par value, 10,000 shares authorized, no shares issued or outstanding | — | — |
| Common stock, no par value, 75,000 shares authorized; 29,579 and 30,432 shares issued and outstanding at December 31, 2025 and 2024, respectively | 231,797 | 252,432 |
| Retained earnings | 123,587 | 108,972 |
| Accumulated other comprehensive loss | (1,361) | (2,049) |
| Total shareholders’ equity | 354,023 | 359,355 |
| Total liabilities and shareholders’ equity | $520,374 | $510,766 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.